Company
United StatesLabcorp Drug Development, Princeton, NJ – FDA Inspections
Inspection records and compliance data for Labcorp Drug Development in Princeton, New Jersey. 7 FDA inspections on record, last inspected April 25, 2022.
Company Profile
This profile covers Labcorp Drug Development based in Princeton, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 0
- NAI
- 7
- Form 483s
- 0
- Warning letters
- 0
First inspected July 15, 2009. Last inspected April 25, 2022.
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 25, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1168630 |
| June 17, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1147393 |
| March 5, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1123056 |
| July 19, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1064469 |
| July 26, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1022660 |
| July 13, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 790402 |
| July 15, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 597131 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Labcorp Drug Development
FEI Number
2242945
Address
206 Carnegie Ctr, Princeton, New Jersey 08540, United States
Country
United States
ID: 590644d8-047e-4701-b6f2-fcb4b881a7a1